IMPAQTT is an independent foundation that contributes substantially to lifesaving new cancer therapies. The focus is on the new treatment options, the so-called targeted therapies. The IMPAQTT Foundation, founded in 2012 as TARGET-RCI, operates as a partner in the management of cancer treatment-associated side effects.
The IMPAQTT Foundation is CancerMed’s Side Effects Research & Valorisation Foundation. CancerMed Side Effects Institute operates as a partner in the management of cancer treatment-associated side effects. While CancerMed Side Effects Institute focuses on the education and certification of health care professionals, the IMPAQTT Foundation focuses on research and valorisation.